PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients [Patient-Oriented and Epidemiological Research]

In conclusion, PCSK7 gene variation is associated with dyslipidemia and more severe liver disease in high risk individuals, likely by modulating PCSK7 expression/activity.

Source: The Journal of Lipid Research - May 31, 2019 Category: Lipidology Authors: Dongiovanni, P., Meroni, M., Baselli, G., Mancina, R. M., Ruscica, M., Longo, M., Rametta, R., Cespiati, A., Pelusi, S., Ferri, N., Ranzani, V., Nobili, V., Pihlajamaki, J., Fracanzani, A. L., Badiali, S., Petta, S., Fargion, S., Romeo, S., Kozlitina, J., Tags: Patient-Oriented and Epidemiological Research Source Type: research